Cryo-cell International, Inc. (CCEL) Cash Flow Statement

Click line-items for a historical chart and %

Net (loss) income	-2.13M
Depreciation and amortization expense
Loss on sale of property and equipment
Compensatory element of stock options	821.42K
Provision for doubtful accounts	578.86K
Write-off of abandoned patents
Equity in losses of affiliate	0
Deferred income tax benefit	-842K
Accounts receivable and advances
Prepaid expenses and other current assets
Deposits and other assets	15.11K
Accounts payable	449.54K
Accrued expenses	-186.18K
Deferred consulting obligation
Deferred revenue	1.51M
Net cash provided by operating activities
Restricted cash held in escrow
Purchases of property and equipment	-298.6K
Purchases of marketable securities and other investments
Proceeds from sale of marketable securities and other investments
Investments in patents and trademarks
Net cash used in investing activities
Proceeds from the exercise of stock options	40.34K
Net cash provided by financing activities
(Decrease) increase in cash and cash equivalents	-2.13M
Cash and cash equivalents - beginning of period	4.15M
Cash and cash equivalents - end of period	2.03M

Entities mentioned with CCEL

View All Entities